23 October 2024
23 October 2024
QbTest uses motion-tracking technology alongside the standard clinical assessment to measure key ADHD symptoms.
The AMStent system represents the first offering within Peytant’s amnion-based covered stent platform.
The study will evaluate the company’s Gen-3 Halo headset as an at-home treatment for mild traumatic brain injury.
The Science Corp study results detailed how patients living with geographic atrophy were able to restore the ability to read sentences using the combination of devices.
The company’s study concluded that its geko wearable could result in cost savings to the NHS of £420m annually.
This approval grants immediate commercial access to these diagnostic tests in the state of New York.
The company is eyeing a pivotal trial for its dual-polymer hydrogel stomach implant following promising first-in-human trial data.
The platform aggregates multimodal patient data and uses generative AI to summarise clinical notes and reports.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
